|
1
|
Denosumab treatment in postmenopausal women with osteoporosis does not interfere with fracture-healing: results from the FREEDOM trial.
|
J Bone Joint Surg Am
|
2012
|
1.54
|
|
2
|
Hormonal changes during menopause.
|
Maturitas
|
2009
|
1.18
|
|
3
|
Duloxetine versus placebo in patients with chronic low back pain: a 12-week, fixed-dose, randomized, double-blind trial.
|
J Pain
|
2010
|
1.14
|
|
4
|
Denosumab compared with ibandronate in postmenopausal women previously treated with bisphosphonate therapy: a randomized open-label trial.
|
Obstet Gynecol
|
2013
|
1.09
|
|
5
|
Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists.
|
Eur Heart J
|
2007
|
1.07
|
|
6
|
Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled Phase 3 study of postmenopausal women with osteoporosis.
|
BMC Musculoskelet Disord
|
2010
|
0.96
|
|
7
|
Prevalence and genotype distribution of human papillomavirus infection of the cervix in Spain: the CLEOPATRE study.
|
J Med Virol
|
2012
|
0.95
|
|
8
|
Tolerability of different oral iron supplements: a systematic review.
|
Curr Med Res Opin
|
2013
|
0.93
|
|
9
|
Menopausal transition in Movima women, a Bolivian Native-American.
|
Maturitas
|
2005
|
0.91
|
|
10
|
Epidemiology of risk factors and symptoms associated with menopause in Spanish women.
|
Maturitas
|
2008
|
0.88
|
|
11
|
Metastatic cutaneous plasmacytoma presenting as a perianal giant mass.
|
Dermatol Online J
|
2008
|
0.84
|
|
12
|
Predictors of human papillomavirus infection in women undergoing routine cervical cancer screening in Spain: the CLEOPATRE study.
|
BMC Infect Dis
|
2012
|
0.83
|
|
13
|
Understanding how personality factors may influence quality of life: development and validation of the Cervantes Personality Scale.
|
Menopause
|
2008
|
0.83
|
|
14
|
Urban-rural differences in Spanish menopausal women.
|
Rural Remote Health
|
2013
|
0.83
|
|
15
|
Leukocytoclastic vasculitis presenting as an erythema gyratum repens--like eruption on a patient with systemic lupus erythematosus.
|
J Am Acad Dermatol
|
2002
|
0.83
|
|
16
|
Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial.
|
J Sex Med
|
2008
|
0.82
|
|
17
|
Effects of odanacatib on BMD and safety in the treatment of osteoporosis in postmenopausal women previously treated with alendronate: a randomized placebo-controlled trial.
|
J Clin Endocrinol Metab
|
2013
|
0.82
|
|
18
|
Efficacy and bleeding profile of a combined oral contraceptive containing oestradiol valerate/dienogest: a pooled analysis of three studies conducted in North America and Europe.
|
Eur J Contracept Reprod Health Care
|
2013
|
0.81
|
|
19
|
[Fibromyalgia and menopause. Association or coincidence?].
|
Ginecol Obstet Mex
|
2011
|
0.81
|
|
20
|
Change to either a nonandrogenic or androgenic progestin-containing oral contraceptive preparation is associated with improved sexual function in women with oral contraceptive-associated sexual dysfunction.
|
J Sex Med
|
2013
|
0.81
|
|
21
|
Is fibromyalgia part of the climacteric syndrome?
|
Maturitas
|
2012
|
0.81
|
|
22
|
Polymorphisms in TRAIL receptor genes and risk of breast cancer in Spanish women.
|
Cancer Biomark
|
2007
|
0.80
|
|
23
|
Neuroprotective effects of soy phytoestrogens in the rat brain.
|
Gynecol Endocrinol
|
2006
|
0.80
|
|
24
|
Third generation SERMs: anything new?
|
Maturitas
|
2010
|
0.78
|
|
25
|
Spanish post-menopausal women's viewpoints on hormone therapy.
|
Maturitas
|
2006
|
0.78
|
|
26
|
Structural validity of a 16-item abridged version of the Cervantes Health-Related Quality of Life scale for menopause: the Cervantes Short-Form Scale.
|
Menopause
|
2015
|
0.78
|
|
27
|
The prescription of hormone replacement therapy in Spain: differences between general practitioners and gynaecologists.
|
Maturitas
|
2006
|
0.78
|
|
28
|
Gynecological care in young women: a high-risk period of life.
|
Gynecol Endocrinol
|
2014
|
0.77
|
|
29
|
Effects on serum lipid and leptin levels of three different doses of norethisterone continuously combined with a fixed dose of 17beta-estradiol for nasal administration in postmenopausal women: a controlled, double-blind study.
|
Fertil Steril
|
2007
|
0.77
|
|
30
|
[Management of cardiovascular risk in the peri-menopausal woman--a consensus statement of European cardiologists and gynaecologists].
|
Kardiol Pol
|
2007
|
0.77
|
|
31
|
Impact of anthropometric parameters on quality of life during menopause.
|
Fertil Steril
|
2008
|
0.77
|
|
32
|
Quality of life in menopausal women: a Brazilian Portuguese version of the Cervantes Scale.
|
ScientificWorldJournal
|
2012
|
0.76
|
|
33
|
Relevant results of the WHI study for the management of the menopause in Spain.
|
Maturitas
|
2003
|
0.76
|
|
34
|
Assessing osteoporosis risk factors in Spanish menopausal women.
|
Gynecol Endocrinol
|
2010
|
0.76
|
|
35
|
Do patients lie? An open interview vs. a blind questionnaire on sexuality.
|
J Sex Med
|
2009
|
0.76
|
|
36
|
Available medical choices for the management of menopause.
|
Maturitas
|
2005
|
0.75
|
|
37
|
Management of the a-symptomatic postmenopausal woman.
|
Maturitas
|
2005
|
0.75
|
|
38
|
[Inhibition of RANK-L in the pathophysiology of osteoporosis. Clinical evidences of its use].
|
Ginecol Obstet Mex
|
2013
|
0.75
|
|
39
|
[General recommendations over perimenopausal transition therapy].
|
Ginecol Obstet Mex
|
2007
|
0.75
|
|
40
|
[Umbilical cutaneous endometriosis associated with a large uterine myoma].
|
Actas Dermosifiliogr
|
2006
|
0.75
|
|
41
|
Endometrium protection and acceptability of nasally administered continuously combined hormone therapy: a multicentre, multinational, double-blind trial in post-menopausal women evaluating three regimens of 17beta-estradiol and norethisterone when compared with an orally administered 17beta-estradiol norethisterone regimen.
|
Hum Reprod
|
2009
|
0.75
|
|
42
|
Effect of conjugated estrogens/bazedoxifene on postmenopausal bone loss: pooled analysis of two randomized trials.
|
Menopause
|
2016
|
0.75
|
|
43
|
[Hyperkeratotic vascular malformations. Presentation of three cases].
|
Actas Dermosifiliogr
|
2005
|
0.75
|
|
44
|
Prevention of postmenopausal bone loss by pulsed estrogen therapy: comparison with transdermal route.
|
Maturitas
|
2004
|
0.75
|
|
45
|
Efficacy of ossein-hydroxyapatite complex compared with calcium carbonate to prevent bone loss: a meta-analysis.
|
Menopause
|
2009
|
0.75
|
|
46
|
[Non-hormonal treatment for vasomotor symptoms during menopause: role of desvenlafaxine].
|
Ginecol Obstet Mex
|
2009
|
0.75
|
|
47
|
Menopause, hormones and sex: the role of the doctor.
|
Maturitas
|
2009
|
0.75
|
|
48
|
[Substitutive hormonal treatment guidelines and risk of endometrial cancer. Data from the Million Women Study].
|
Med Clin (Barc)
|
2005
|
0.75
|
|
49
|
Practical recommendations for hormone replacement therapy in the peri- and postmenopause.
|
Climacteric
|
2004
|
0.75
|